SAN DIEGO / May 28, 2024 / Business Wire / Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business. Cue has been working diligently to strengthen the Company’s financial foundation, including taking a number of actions to... Read More

SAN DIEGO / May 13, 2024 / Business Wire / Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the “Company”), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days. About Cue Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology... Read More

SAN DIEGO / Apr 29, 2024 / Business Wire / Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call. About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their... Read More

Clint Sever Appointed CEO Board Appoints Two Strategic Advisors Who Bring Significant Industry Expertise SAN DIEGO / Mar 20, 2024 / Business Wire / Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the “Board”) to best position the Company for its next stage: Clint Sever, co-founder and current Chief Product... Read More

SAN DIEGO / Mar 13, 2024 / Business Wire / Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent Highlights Reported fourth quarter total revenue of $18.8 million. Full-year 2023 total revenue was $70.9 million Submitted additional clinical samples and stability data for RSV to the FDA in support of de novo... Read More

SAN DIEGO / Feb 28, 2024 / Business Wire / Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent... Read More

SAN DIEGO / Feb 16, 2024 / Business Wire / Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced it entered into a cooperation agreement (the “Cooperation Agreement”) with Tarsadia Investments (“Tarsadia”), and appointed Rishi Reddy to its board of directors (the “Board”), effective immediately. Mr. Reddy is a Managing Director at Tarsadia, where he leads the firm’s venture and growth equity strategy.... Read More

SAN DIEGO / Jan 31, 2024 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024. About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their... Read More

SAN DIEGO / Nov 08, 2023 / Business Wire / Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter 2023. Recent Highlights Reported third quarter total revenue of $17.5 million, approximately 50% above the midpoint of our guidance range of $11 to $13 million. Three tests in review with the FDA: Cue® Flu A/B + COVID-19 Multiplex Molecular Test Emergency... Read More

SAN DIEGO / Oct 25, 2023 / Business Wire / Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. To access... Read More

Cue Health founder and investor, Kelly Day, and certain other stockholders Calls on the Board to reign in undisciplined expansion and cut expenditures Board should include direct stockholder representation to hold management to account LOS ANGELES / Oct 06, 2023 / Business Wire / Kelly Day and other concerned stockholders who collectively own 7.5% of Cue Health, Inc. (the “Company” or “Cue Health”) (NASDAQ: HLTH) outstanding... Read More

In largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR SAN DIEGO / Oct 04, 2023 / Business Wire / Cue Health (Nasdaq: HLTH), a healthcare technology company, announced today the peer-reviewed publication of an independent clinical study - the largest of its kind on asymptomatic people - finding that Cue’s molecular COVID-19 test provides comparable accuracy to... Read More

Board of Directors Takes Action to Protect Long-Term Value for All Shareholders Rights Plan Responds to Significant Third-Party Share Accumulation SAN DIEGO / Sep 21, 2023 / Business Wire / Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the “Rights Plan”) to protect the long-term... Read More

SAN DIEGO / Aug 23, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences: 2023 Wells Fargo Healthcare Conference Presenting via fireside chat on Wednesday, September 6, 2023 at 3:00 p.m. Eastern Time in Boston, MA at the Encore Boston Harbor Morgan Stanley 21 st Annual Global Healthcare Conference... Read More

SAN DIEGO / Aug 09, 2023 / Business Wire / Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the second quarter 2023. Recent Highlights Reported second quarter total revenue of $10 million at the top-end of our guidance. Received landmark first, over-the-counter De Novo authorization from the FDA for the Cue COVID-19 Molecular Test. Awarded a new $28.3 million... Read More

The test will be designed to detect and differentiate between the four viruses and deliver results in approximately 25 minutes SAN DIEGO / Aug 03, 2023 / Business Wire / Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic... Read More

SAN DIEGO, Calif. / Jul 26, 2023 / Business Wire / Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2023 financial results on Wednesday, August 9, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. To... Read More

Cue’s COVID-19 Molecular Test detects all known variants of concern and seamlessly integrates with Cue Care, the company’s innovative test-to-treatment platform SAN DIEGO / Jun 06, 2023 / Business Wire / Cue Health (Nasdaq: HLTH), a healthcare technology company, announces an industry breakthrough as the first company to... Read More

SAN DIEGO, Calif. / May 31, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the Goldman Sachs 44 th Annual Global Healthcare Conference on Wednesday, June 14, 2023 at 4:00 p.m. Pacific Time at the Waldorf Astoria Monarch Beach Resort & Club. A live audio webcast and replay of the presentation may be accessed for 180 days on... Read More

SAN DIEGO / May 10, 2023 / Business Wire / Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the first quarter 2023. Recent Highlights Reported first quarter revenue of $24.8 million Granted U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for Cue Mpox (Monkeypox) Molecular Test for point-of-care use Submitted the Cue RSV Molecular Test as a... Read More

SAN DIEGO / May 09, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care use. There are currently no respiratory syncytial virus (RSV) tests on the market for home use. Pending FDA clearance, Cue’s test would... Read More

Cue now offers over-the-counter and prescription medications for sexual health, birth control, hair loss, and more SAN DIEGO / May 08, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription medication options for a growing number of common health and... Read More

SAN DIEGO / Apr 26, 2023 / Business Wire / Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. To access the... Read More

SAN DIEGO / Mar 20, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its molecular test to detect the mpox virus (formerly known as monkeypox). This nucleic acid amplification test (NAAT) is run on a Cue Reader, can be performed at any CLIA-waived facility... Read More

SAN DIEGO / Mar 15, 2023 / Business Wire / Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022. Recent and Full-Year 2022 Highlights Reported fourth quarter revenue of $146.8 million, including $92.4 million in deferred revenue related to our agreement with the U.S. Department of Defense. Full-year 2022 revenue was $483.5 million.... Read More

SAN DIEGO / Mar 13, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits. These easy-to-use kits provide individuals with access to accurate, reliable testing from the comfort of their own homes, making it easier for people to take control of their health. The tests are integrated into... Read More

SAN DIEGO / Mar 02, 2023 / Business Wire / Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc. in the U.S. to raise awareness among individuals with certain underlying conditions about the risks of progressing to severe COVID-19 and the importance of seeking treatment if they test positive. Through Cue... Read More

In partnership with Minnesota Department of Health, Cue’s digital service offers an integrated solution to provide COVID-19 treatment options access across all populations Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, today announced that it has been selected by Minnesota Department of Health (MDH) to provide a statewide COVID-19 telehealth to treatment program ,... Read More